Table of Contents Author Guidelines Submit a Manuscript
Journal of Cancer Epidemiology
Volume 2012 (2012), Article ID 506410, 8 pages
http://dx.doi.org/10.1155/2012/506410
Research Article

Screening and Health Behaviors among Persons Diagnosed with Familial Adenomatous Polyposis and Their Relatives

1Division of Public Health Sciences, Department of Surgery, Washington University in Saint Louis, 660 So. Euclid Avenue, P.O. Box 8100, Saint Louis, MO 63110, USA
2Department of Medicine, Washington University in Saint Louis, 4950 Children's place St. Louis, MO 63110, USA
3Siteman Cancer Center, Washington University in Saint Louis, 660 So. Euclid Avenue, P.O. Box 8100, Saint Louis, MO 63110, USA
4Division of Gastroenterology, Department of Medicine, Washington University in Saint Louis, 660 So. Euclid Avenue, P.O. Box 8124, Saint Louis, MO 63110, USA

Received 16 March 2012; Revised 8 June 2012; Accepted 19 June 2012

Academic Editor: Laura Koehly

Copyright © 2012 Aimee S. James et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. ACS, Cancer Facts and Figures, 2011, American Cancer Society, Atlanta, Ga, USA, 2011.
  2. P. Lichtenstein, N. V. Holm, P. K. Verkasalo et al., “Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland,” The New England Journal of Medicine, vol. 343, no. 2, pp. 78–85, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Bülow, T. Faurschou Nielsen, C. Bülow, M. L. Bisgaard, L. Karlsen, and F. Moesgaard, “The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register,” International Journal of Colorectal Disease, vol. 11, no. 2, pp. 88–91, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Half, D. Bercovich, and P. Rozen, “Familial adenomatous polyposis,” Orphanet Journal of Rare Diseases, vol. 4, no. 1, article 22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. K. W. Jasperson, T. M. Tuohy, D. W. Neklason, and R. W. Burt, “Hereditary and familial colon cancer,” Gastroenterology, vol. 138, no. 6, pp. 2044–2058, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. P. M. Lynch, “Prevention of colorectal cancer in high-risk populations: the increasing role for endoscopy and chemoprevention in FAP and HNPCC,” Digestion, vol. 76, no. 1, pp. 68–76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. L. L. Strate and S. Syngal, “Hereditary colorectal cancer syndromes,” Cancer Causes and Control, vol. 16, no. 3, pp. 201–213, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. O. M. Sieber, H. Lamlum, M. D. Crabtree et al., “Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or “multiple” colorectal adenomas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 5, pp. 2954–2958, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Aretz, D. Stienen, S. Uhlhaas et al., “Large submicroscopic genomic APC deletions are a common cause of typical familial adenomatous polyposis,” Journal of Medical Genetics, vol. 42, no. 2, pp. 185–192, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. K. F. L. Douma, N. K. Aaronson, H. F. A. Vasen, and E. M. A. Bleiker, “Psychosocial issues in genetic testing for familial adenomatous polyposis: a review of the literature,” Psycho-Oncology, vol. 17, no. 8, pp. 737–745, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. K. F. L. Douma, E. M. Bleiker, N. K. Aaronson et al., “Distress and use of professional psychosocial support in individuals from families at high-risk for familial adenomatous polyposis (FAP),” Psycho-Oncology, vol. 17, pp. S159–S159, 2008. View at Google Scholar
  12. J. Church and C. Simmang, “Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer),” Diseases of the Colon and Rectum, vol. 46, no. 8, pp. 1001–1012, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. CDC, “Cancer screening—United States, 2010,” Morbidity and Mortality Weekly Report, vol. 61, no. 3, pp. 41–45, 2012. View at Google Scholar
  14. E. K. L. Mallinson, K. F. Newton, J. Bowen et al., “The impact of screening and genetic registration on mortality and colorectal cancer incidence in familial adenomatous polyposis,” Gut, vol. 59, no. 10, pp. 1378–1382, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Michie, V. Collins, D. Eccles et al., “Likelihood of attending bowel screening after a negative genetic test result: the possible influence of health professionals,” Genetic Testing, vol. 6, no. 4, pp. 307–311, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Y. Kinney, B. Hicken, S. E. Simonsen et al., “Colorectal cancer surveillance behaviors among members of typical and attenuated FAP families,” American Journal of Gastroenterology, vol. 102, no. 1, pp. 153–162, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. E. M. Stoffel, R. C. Mercado, W. Kohlmann et al., “Prevalence and predictors of appropriate colorectal cancer surveillance in lynch syndrome,” American Journal of Gastroenterology, vol. 105, no. 8, pp. 1851–1860, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. W. Hadley, J. F. Jenkins, E. Dimond, M. De Carvalho, I. Kirsch, and C. G. S. Palmer, “Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer,” Journal of Clinical Oncology, vol. 22, no. 1, pp. 39–44, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. A. M. Burton, S. K. Peterson, S. K. Marani et al., “Health and lifestyle behaviors among persons at risk of Lynch syndrome,” Cancer Causes and Control, vol. 21, no. 4, pp. 513–521, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. L. Ersig, D. W. Hadley, and L. M. Koehly, “Colon cancer screening practices and disclosure after receipt of positive or inconclusive genetic test results for hereditary nonpolyposis colorectal cancer,” Cancer, vol. 115, no. 18, pp. 4071–4079, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. K. F. L. Douma, E. M. A. Bleiker, N. K. Aaronson et al., “Long-term compliance with endoscopic surveillance for familial adenomatous polyposis,” Colorectal Disease, vol. 12, no. 12, pp. 1198–1207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. W. Vernon, H. Meissner, C. Klabunde et al., “Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research,” Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 6, pp. 898–905, 2004. View at Google Scholar · View at Scopus
  23. K. Bartuma, M. Nilbert, and C. Carlsson, “Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations,” Hereditary Cancer in Clinical Practice, vol. 10, no. 1, article 6, 2012. View at Google Scholar
  24. K. Glanz, J. Grove, C. Lerman, C. Gotay, and L. Le Marchand, “Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups,” Cancer Epidemiology Biomarkers and Prevention, vol. 8, no. 4, part 2, pp. 329–336, 1999. View at Google Scholar · View at Scopus
  25. A. M. Codori, G. M. Petersen, D. L. Miglioretti et al., “Attitudes toward colon cancer gene testing: factors predicting test uptake,” Cancer Epidemiology Biomarkers and Prevention, vol. 8, no. 4, part 2, pp. 345–351, 1999. View at Google Scholar · View at Scopus
  26. G. M. Petersen, E. Larkin, A. M. Codori et al., “Attitudes toward colon cancer gene testing: survey of relatives of colon cancer patients,” Cancer Epidemiology Biomarkers and Prevention, vol. 8, no. 4, part 2, pp. 337–344, 1999. View at Google Scholar · View at Scopus
  27. C. M. Condit, “Public attitudes and beliefs about genetics,” Annual Review of Genomics and Human Genetics, vol. 11, pp. 339–359, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. C. M. McBride, D. Bowen, L. C. Brody et al., “Future health applications of genomics: priorities for communication, behavioral, and social sciences research,” American Journal of Preventive Medicine, vol. 38, no. 5, pp. 556–565, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. C. M. Condit, “Public understandings of genetics and health,” Clinical Genetics, vol. 77, no. 1, pp. 1–9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. M. McAllister, “Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing,” Clinical Genetics, vol. 64, no. 3, pp. 179–189, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. K. K. Tsoi, C. Y. Y. Pau, W. K. K. Wu et al., “Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies,” Clinical Gastroenterology and Hepatology, vol. 7, no. 6, pp. 682.e5–688.e5, 2009. View at Publisher · View at Google Scholar
  32. P. J. Limburg, R. A. Vierkant, J. R. Cerhan et al., “Cigarette smoking and colorectal cancer: long-term, subsite-specific risks in a cohort study of postmenopausal women,” Clinical Gastroenterology and Hepatology, vol. 1, no. 3, pp. 202–210, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. R. M. Winkels, A. Botma, F. J. B. van Duijnhoven et al., “Smoking increases the risk for colorectal adenomas in patients with Lynch syndrome,” Gastroenterology, vol. 142, no. 2, pp. 241–247, 2012. View at Publisher · View at Google Scholar
  34. P. Watson, R. Ashwathnarayan, H. T. Lynch, and H. K. Roy, “Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome),” Archives of Internal Medicine, vol. 164, no. 22, pp. 2429–2431, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Eddi, A. Karki, A. Shah et al., “Association of type 2 diabetes and colon adenomas,” Journal of Gastrointestinal Cancer, vol. 43, no. 1, pp. 87–92, 2012. View at Google Scholar
  36. T. Morita, S. Tabata, M. Mineshita, T. Mizoue, M. A. Moore, and S. Kono, “The metabolic syndrome is associated with increased risk of colorectal adenoma development: the Self-Defense Forces health study,” Asian Pacific Journal of Cancer Prevention, vol. 6, no. 4, pp. 485–489, 2005. View at Google Scholar · View at Scopus
  37. J. Luo, R. Chlebowski, J. Wactawski-Wende et al., “Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausalwomen,” Cancer Causes and Control. In press.
  38. L. Deng, Z. Gui, L. Zhao et al., “Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis,” Digestive Diseases and Sciences, vol. 57, no. 6, pp. 1576–1585, 2012. View at Publisher · View at Google Scholar
  39. J. He, D. O. Stram, L. N. Kolonel, B. E. Henderson, L. Le Marchand, and C. A. Haiman, “The association of diabetes with colorectal cancer risk: the Multiethnic Cohort,” British Journal of Cancer, vol. 103, no. 1, pp. 120–126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. S. C. Larsson, N. Orsini, and A. Wolk, “Diabetes mellitus and risk of colorectal cancer: a meta-analysis,” Journal of the National Cancer Institute, vol. 97, no. 22, pp. 1679–1687, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. P. A. Jänne and R. J. Mayer, “Chemoprevention of colorectal cancer,” The New England Journal of Medicine, vol. 342, no. 26, pp. 1960–1968, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Burn, D. T. Bishop, P. D. Chapman et al., “A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis,” Cancer Prevention Research, vol. 4, no. 5, pp. 655–665, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. J. A. Baron, “Epidemiology of non-steroidal anti-inflammatory drugs and cancer,” Progress in Experimental Tumor Research, vol. 37, pp. 1–24, 2003. View at Google Scholar · View at Scopus
  44. E. J. Jacobs, M. J. Thun, E. B. Bain, C. Rodriguez, S. J. Henley, and E. E. Calle, “A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence,” Journal of the National Cancer Institute, vol. 99, no. 8, pp. 608–615, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Flossmann and P. M. Rothwell, “Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies,” The Lancet, vol. 369, no. 9573, pp. 1603–1613, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Cooper, H. Squires, C. Carroll et al., “Chemoprevention of colorectal cancer: systematic review and economic evaluation,” Health Technology Assessment, vol. 14, no. 32, pp. 1–206, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. S. A. Buckman and C. P. Heise, “Nutrition considerations surrounding restorative proctocolectomy,” Nutrition in Clinical Practice, vol. 25, no. 3, pp. 250–256, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Almendingen, O. Fausa, A. T. Høstmark et al., “Serum nutrients and habitual dietary intake in colectomized FAP patients in Norway,” European Journal of Nutrition, vol. 48, no. 3, pp. 129–136, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Half and N. Arber, “Colon cancer: preventive agents and the present status of chemoprevention,” Expert Opinion on Pharmacotherapy, vol. 10, no. 2, pp. 211–219, 2009. View at Publisher · View at Google Scholar · View at Scopus